Uv Flu Technologies (UVFT) 0.0300 $UVFT
UV Flu Technologies Signs Distribution Letter of Intent
Marketwire - Tue Apr 08, 7:25AM CDT
UV Flu Technologies, Inc. (OTCBB: UVFT) ("UVFT"
has signed a letter of intent with a distribution partner for the exclusive rights for retail distribution of UVFT's FDA-cleared ViraTech(TM) UV-400 air purifier that kills more than 99% of airborne bacteria. The distributor has paid a non-refundable $25,000 deposit and the distribution agreement is expected to close by April 21st.
UV Flu Technologies to Spearhead Initiatives Aimed at Medical Marijuana Air Problems
Marketwire - Mon Mar 10, 7:45AM CDT
UV Flu Technologies, Inc. (OTCBB: UVFT) (OTCQB: UVFT) (the "Company" announced today that Company is planning marketing initiatives for its line of FDA Cleared air purifier products. The company is focused on selling its RX-Air Line to growers and dispensaries for in-house use and distribution through the dispensaries to consumers of the companies UV-400 unit. The company hopes this will help resolve issues with Indoor Air Quality Risks associated with the burgeoning markets for medical and legalized marijuana.
MeeMee Media Inc. (OTCQB: MEME) Announces Completion of $1 Million Private Placement
PR Newswire - Wed Feb 12, 7:00AM CST
MeeMee Media Inc. (the "Company" or "MeeMee" ) (OTCQB: MEME), a development stage company focused on the global mobile and digital media business, announces it has closed a $1 million USD private placement by way of a Secured Promissory Note ("Note" with an entity controlled by Mr. Robert C. Kopple of Los Angeles, California. The net proceeds of the Note will be used for general working capital, including legal, accounting, diligence and banking fees required to complete the previously announced, planned acquisitions of the Latin American mobile content company and Vida Media.
CES Wrap-Up: UV Flu Technologies and Vystar Corp.'s "Perfect Sleep Environment" Attracts Global Interest
Marketwire - Tue Jan 14, 9:07AM CST
For the first time, UV Flu Technologies (OTCBB: UVFT) and Vystar Corporation's (OTCBB: VYST) shared an international stage with the world's most innovative companies at the Consumer Electronics Show (CES) as the two companies showcased "The Perfect Sleep Environment" with Vystar's Vytex(R) Natural Rubber Latex (NRL) pillow and UVFT's UV-based, microbe-, spore- and germ-killing air purification system. The technologies attracted the attention of numerous new manufacturers and suppliers that have been actively seeking these solutions. Vystar and UVFT are now further exploring multiple business opportunities worldwide and have moved closer to finalizing multi-million dollar contracts with potential partners, manufacturers, suppliers and distributors.
CDC Predicts Spread of Airborne Diseases to Have Catastrophic Consequences
ACCESSWIRE - Thu Sep 19, 7:40AM CDT
BARNSTABLE, MA, September 19, 2013 - (Accesswire) - UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company" announced today that the warning issued this week from the CDC, or Center for Disease Control, relating to the threats from strains of bacteria that have grown impervious to bacteria, may only scratch the surface with respect to the overall threat. The health warning did estimate that at least 2 million people in this country become infected with bacteria that are resistant to antibiotics, and that at least 23,000 people die each year as a result of these infections. Thousands more die from infections contracted in hospitals, as well as from other conditions that were complicated by antibiotic-resistant infections.
UV Flu Technologies Inc to increase shareholder value with RxAir's planned spinoff
M2 - Mon Jun 24, 7:02AM CDT
The board of directors of UV Flu Technologies Inc (OTCQB:UVFT), a bio technology company, said on Friday that it has authorised its management to pursue the spinoff of its RxAir business into a separate publicly-traded entity.
UV Flu Approves Plan to Maximize Shareholder Value With Spinoff of RxAir
Marketwire - Fri Jun 21, 7:30AM CDT
UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company" announced today that the Board of Directors has authorized management to pursue the spinoff of its RxAir business into a separate publicly-traded entity. The RxAir division will concentrate entirely on the medical and commercial markets, while the parent will continue to concentrate on the residential marketplace.
UV Flu Technologies Board of Directors Approve the Spin Off of RxAir
ACCESSWIRE - Thu Jun 20, 7:34AM CDT
BARNSTABLE, MA, June 20, 2013 - UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company" announced today that the Board of Directors has authorized management to pursue the spinoff of its RxAir business into a separate publicly-traded entity. The RxAir division will concentrate entirely on the medical and commercial markets, while the parent will continue to concentrate on the residential marketplace.
UV Flu Technology Forecasts Record Allergy Season and Revenues
PR Newswire - Wed Apr 03, 7:30AM CDT
UV Flu Technologies, Inc. (OTCQB: UVFT)(the "Company" announced today that the Company is forecasting that this year may the worst allergy season ever, particularly in the Northeast, as well as many northern states.
UV Flu Technology Commences National TV Brand Awareness Campaign
PR Newswire - Wed Mar 27, 7:30AM CDT
UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company" announced today that the Company has retained Stardust Broadcasting to run approximately 500 sixty-second television spots on a variety of national stations, with the intent of building the brand, and educating the consumer about the dangers of indoor air pollution.
UV Flu Technologies Signs Distribution Letter of Intent
Marketwire - Tue Apr 08, 7:25AM CDT
UV Flu Technologies, Inc. (OTCBB: UVFT) ("UVFT"
has signed a letter of intent with a distribution partner for the exclusive rights for retail distribution of UVFT's FDA-cleared ViraTech(TM) UV-400 air purifier that kills more than 99% of airborne bacteria. The distributor has paid a non-refundable $25,000 deposit and the distribution agreement is expected to close by April 21st. UV Flu Technologies to Spearhead Initiatives Aimed at Medical Marijuana Air Problems
Marketwire - Mon Mar 10, 7:45AM CDT
UV Flu Technologies, Inc. (OTCBB: UVFT) (OTCQB: UVFT) (the "Company"
announced today that Company is planning marketing initiatives for its line of FDA Cleared air purifier products. The company is focused on selling its RX-Air Line to growers and dispensaries for in-house use and distribution through the dispensaries to consumers of the companies UV-400 unit. The company hopes this will help resolve issues with Indoor Air Quality Risks associated with the burgeoning markets for medical and legalized marijuana. MeeMee Media Inc. (OTCQB: MEME) Announces Completion of $1 Million Private Placement
PR Newswire - Wed Feb 12, 7:00AM CST
MeeMee Media Inc. (the "Company" or "MeeMee" ) (OTCQB: MEME), a development stage company focused on the global mobile and digital media business, announces it has closed a $1 million USD private placement by way of a Secured Promissory Note ("Note"
with an entity controlled by Mr. Robert C. Kopple of Los Angeles, California. The net proceeds of the Note will be used for general working capital, including legal, accounting, diligence and banking fees required to complete the previously announced, planned acquisitions of the Latin American mobile content company and Vida Media. CES Wrap-Up: UV Flu Technologies and Vystar Corp.'s "Perfect Sleep Environment" Attracts Global Interest
Marketwire - Tue Jan 14, 9:07AM CST
For the first time, UV Flu Technologies (OTCBB: UVFT) and Vystar Corporation's (OTCBB: VYST) shared an international stage with the world's most innovative companies at the Consumer Electronics Show (CES) as the two companies showcased "The Perfect Sleep Environment" with Vystar's Vytex(R) Natural Rubber Latex (NRL) pillow and UVFT's UV-based, microbe-, spore- and germ-killing air purification system. The technologies attracted the attention of numerous new manufacturers and suppliers that have been actively seeking these solutions. Vystar and UVFT are now further exploring multiple business opportunities worldwide and have moved closer to finalizing multi-million dollar contracts with potential partners, manufacturers, suppliers and distributors.
CDC Predicts Spread of Airborne Diseases to Have Catastrophic Consequences
ACCESSWIRE - Thu Sep 19, 7:40AM CDT
BARNSTABLE, MA, September 19, 2013 - (Accesswire) - UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company"
announced today that the warning issued this week from the CDC, or Center for Disease Control, relating to the threats from strains of bacteria that have grown impervious to bacteria, may only scratch the surface with respect to the overall threat. The health warning did estimate that at least 2 million people in this country become infected with bacteria that are resistant to antibiotics, and that at least 23,000 people die each year as a result of these infections. Thousands more die from infections contracted in hospitals, as well as from other conditions that were complicated by antibiotic-resistant infections. UV Flu Technologies Inc to increase shareholder value with RxAir's planned spinoff
M2 - Mon Jun 24, 7:02AM CDT
The board of directors of UV Flu Technologies Inc (OTCQB:UVFT), a bio technology company, said on Friday that it has authorised its management to pursue the spinoff of its RxAir business into a separate publicly-traded entity.
UV Flu Approves Plan to Maximize Shareholder Value With Spinoff of RxAir
Marketwire - Fri Jun 21, 7:30AM CDT
UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company"
announced today that the Board of Directors has authorized management to pursue the spinoff of its RxAir business into a separate publicly-traded entity. The RxAir division will concentrate entirely on the medical and commercial markets, while the parent will continue to concentrate on the residential marketplace. UV Flu Technologies Board of Directors Approve the Spin Off of RxAir
ACCESSWIRE - Thu Jun 20, 7:34AM CDT
BARNSTABLE, MA, June 20, 2013 - UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company"
announced today that the Board of Directors has authorized management to pursue the spinoff of its RxAir business into a separate publicly-traded entity. The RxAir division will concentrate entirely on the medical and commercial markets, while the parent will continue to concentrate on the residential marketplace. UV Flu Technology Forecasts Record Allergy Season and Revenues
PR Newswire - Wed Apr 03, 7:30AM CDT
UV Flu Technologies, Inc. (OTCQB: UVFT)(the "Company"
announced today that the Company is forecasting that this year may the worst allergy season ever, particularly in the Northeast, as well as many northern states. UV Flu Technology Commences National TV Brand Awareness Campaign
PR Newswire - Wed Mar 27, 7:30AM CDT
UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company"
announced today that the Company has retained Stardust Broadcasting to run approximately 500 sixty-second television spots on a variety of national stations, with the intent of building the brand, and educating the consumer about the dangers of indoor air pollution. 
